Ticker
INOCompany Name
INOVIO PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Invested Capital | Net Income Common Stock | Return on Invested Capital |
---|---|---|---|
6/30/2025 | $ 39.19M | $ -87.76M | -223.94% |
3/31/2025 | $ 62.52M | $ -96.48M | -154.31% |
12/31/2024 | $ 80.37M | $ -107.25M | -133.45% |
9/30/2024 | $ 85.99M | $ -112.88M | -131.27% |
6/30/2024 | $ 109.72M | $ -121.64M | -110.87% |
3/31/2024 | $ 107.87M | $ -124.94M | -115.82% |
12/31/2023 | $ 147.56M | $ -135.12M | -91.57% |
9/30/2023 | $ 167.96M | $ -164.58M | -97.99% |
6/30/2023 | $ 200.13M | $ -168.43M | -84.16% |
3/31/2023 | $ 230.37M | $ -241.39M | -104.78% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Inv. Capital
(=) ROIC
ROIC for INOVIO PHARMACEUTICALS INC is calculated as follows: Net Inc. Cmn. [ $ -179.73M ] / Inv. Capital [ $ 398.53M ]
(=) ROIC [ -45.1% ]
Minimum
Jun 30, 2025
Maximum
Jun 30, 2021
Average
Median
filtered constituents | 3.36K |
---|---|
min | -46.36% |
max | 48.66% |
average | 0.68% |
median | 3.38% |
std | 15.2% |